Cargando…
Treatment of facial hypertrophic capillary malformations with tumescent‐assisted sclerotherapy
Facial capillary malformations (CMs) become hypertrophic and nodular overtime and pose great therapeutic challenge. Here, we describe safe and effective use of tumescent‐assisted sclerotherapy (TAS) in conjunction with yellow vascular laser (577 nm) for the treatment of HFCMs. Three patients underwe...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9321826/ https://www.ncbi.nlm.nih.gov/pubmed/35411941 http://dx.doi.org/10.1111/ajd.13838 |
_version_ | 1784756143702147072 |
---|---|
author | Kang, Mina Parsi, Kurosh |
author_facet | Kang, Mina Parsi, Kurosh |
author_sort | Kang, Mina |
collection | PubMed |
description | Facial capillary malformations (CMs) become hypertrophic and nodular overtime and pose great therapeutic challenge. Here, we describe safe and effective use of tumescent‐assisted sclerotherapy (TAS) in conjunction with yellow vascular laser (577 nm) for the treatment of HFCMs. Three patients underwent TAS were included in the case series, and complete resolution in nodularity was achieved in all patients with TAS, with no major complications such as skin necrosis, distal embolisation, blindness and neurological adverse events such as stroke or TIA occurred in any patients. |
format | Online Article Text |
id | pubmed-9321826 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-93218262022-07-30 Treatment of facial hypertrophic capillary malformations with tumescent‐assisted sclerotherapy Kang, Mina Parsi, Kurosh Australas J Dermatol Procedural Dermatology (Direct via Eeo) Facial capillary malformations (CMs) become hypertrophic and nodular overtime and pose great therapeutic challenge. Here, we describe safe and effective use of tumescent‐assisted sclerotherapy (TAS) in conjunction with yellow vascular laser (577 nm) for the treatment of HFCMs. Three patients underwent TAS were included in the case series, and complete resolution in nodularity was achieved in all patients with TAS, with no major complications such as skin necrosis, distal embolisation, blindness and neurological adverse events such as stroke or TIA occurred in any patients. John Wiley and Sons Inc. 2022-04-12 2022-05 /pmc/articles/PMC9321826/ /pubmed/35411941 http://dx.doi.org/10.1111/ajd.13838 Text en © 2022 The Authors. Australasian Journal of Dermatology published by John Wiley & Sons Australia, Ltd on behalf of Australasian College of Dermatologists. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Procedural Dermatology (Direct via Eeo) Kang, Mina Parsi, Kurosh Treatment of facial hypertrophic capillary malformations with tumescent‐assisted sclerotherapy |
title | Treatment of facial hypertrophic capillary malformations with tumescent‐assisted sclerotherapy |
title_full | Treatment of facial hypertrophic capillary malformations with tumescent‐assisted sclerotherapy |
title_fullStr | Treatment of facial hypertrophic capillary malformations with tumescent‐assisted sclerotherapy |
title_full_unstemmed | Treatment of facial hypertrophic capillary malformations with tumescent‐assisted sclerotherapy |
title_short | Treatment of facial hypertrophic capillary malformations with tumescent‐assisted sclerotherapy |
title_sort | treatment of facial hypertrophic capillary malformations with tumescent‐assisted sclerotherapy |
topic | Procedural Dermatology (Direct via Eeo) |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9321826/ https://www.ncbi.nlm.nih.gov/pubmed/35411941 http://dx.doi.org/10.1111/ajd.13838 |
work_keys_str_mv | AT kangmina treatmentoffacialhypertrophiccapillarymalformationswithtumescentassistedsclerotherapy AT parsikurosh treatmentoffacialhypertrophiccapillarymalformationswithtumescentassistedsclerotherapy |